Latest Strategy News

Mont Royal Resources is on track to release an updated Preliminary Economic Assessment for its Ashram Rare Earths project in May, with a promising geological review highlighting the BD-Zone as a key area for resource expansion. The company also secured a strategic non-binding MOU with Saguenay Port Authority and extended funding for critical infrastructure.

Syrah Resources delivered a record 24kt graphite production at Balama and secured US$72 million in equity to support medium-term ramp-up and Vidalia commercialisation, navigating a complex US trade environment.

Avecho Biotechnology has exceeded its Phase III CBD insomnia trial recruitment target by 16%, setting the stage for a more robust interim analysis scheduled for June 2026. The company’s commercial partnership with Sandoz AG and strengthened patent portfolio underpin its Australian market strategy.

Prospect Resources has delivered further gold assay results from its Nyungu Central deposit, reinforcing the potential for valuable by-product credits at the Mumbezhi Copper Project and setting the stage for an aggressive Phase 3 drilling campaign.

TrivarX appoints Dr Danielle Meyrick as CEO to spearhead clinical trials and commercialisation of its novel stable isotope MRI brain cancer imaging platform, with Phase 1 studies on track for completion this year.

Mamba Exploration has secured a controlling stake in the Meeka East Gold Project, bolstered by a $2 million capital raise and promising early exploration work including extensive soil sampling and historic data validation.

Metal Powder Works has scaled its NextGen powder production to 100 metric tonnes per annum with an industry-leading saleable yield above 95%, setting the stage for an 800MT capacity by 2028 at a fraction of conventional costs.

Nova Eye Medical reported a 23% rise in quarterly sales to US$5.8 million, driven by strong US growth and initial Chinese sales. EBITDA loss narrowed significantly, with positive operational EBITDA recorded.

Sea Forest Limited’s 3Q26 revenue surged 92% to $1.1 million, boosted by expanding SeaFeed™ sales and a pioneering low-carbon wool launch with Theory. New cattle supply deals raise herd commitments to 131,000, underpinning growth amid supportive government policies.

Lotus Resources has completed the first phase of a 10,000m infill drill program at its Letlhakane Uranium Project, revealing significant higher-grade uranium intercepts that underpin a resource upgrade planned for H2 2026.

RocketDNA Ltd delivered a break-even operating cash flow quarter with $2.47 million revenue, driven by soaring autonomous drone usage and the debut of its Skylink® operating system.

Enlitic delivered its strongest quarter yet with A$5.1 million in contracts, including significant agreements with Penn Medicine, St. Jude Children’s Research Hospital, and Parkland Health, while improving cash flow and advancing its AI-powered Ensight platform.